Searchable abstracts of presentations at key conferences in endocrinology

ea0030p20 | (1) | BSPED2012

Uptake of 2009 BSPED guidelines in Northern East England and North Cumbria

Srinivasan Ramesh , Ahmed Jannath , Cheetham Tim , Agbeko Rachel

Background: Diabetic ketoacidosis (DKA) remains the leading cause of morbidity and mortality in children with type 1 diabetes. In the past few years, both the International Society for Paediatric and Adolescent Diabetes (ISPAD) and the British Society for Paediatric Endocrinology and Diabetes (BSPED) have recommended key changes in the management of DKA. These changes incorporate new evidence to reduce the incidence of cerebral oedema and the increased use of insulin pumps.</p...

ea0030p30 | (1) | BSPED2012

Audit of diabetic ketoacidosis management in adolescents in paediatric and adult care settings

Ahmed Jannath , Srinivasan Ramesh , Anderson Mark , Agbeko Rachel

Introduction: Guidance on the management of diabetic ketoacidosis (DKA) has recently been updated in an effort to reduce the risk of complications, in particular, cerebral oedema. However, differences in recommendations for children and adults persist making the care of teenagers with DKA confusing and potentially hazardous.Aims: To compare the management of DKA in teenage patients in paediatric and adult care settings in the context of the latest nation...

ea0028p7 | Bone | SFEBES2012

Audit on the management of primary hyperparathyroidism by parathyroidectomy

Koppa Narayana Shashithej , Ward Kirsty , Ahmed Abu Baker

Diagnosis of primary hyperparathyroidism is often made incidentally following routine biochemical screening. Parathyroidectomy is usually carried out in patients at risk of disease progression or with clinical features that may improve and that is in line with NIH guidance. Current recommendations suggest that Minimally Invasive Parathyroidectomy (MIP) should take place only if sestamibi and ultrasound findings are concordant. We studied the medical notes of 53 patients, aged ...

ea0028p11 | Bone | SFEBES2012

Evaluation of the surgical management of primary hyperparathyroidism in a tertiary referral unit

Kaimal Nisha , Bonello Victoria , Ahmed Babur , Kearney Tara , Doran Helen

Aim: We performed a retrospective analysis to evaluate the surgical treatment of primary hyperparathyroidism in a tertiary referral centre.Methods: We reviewed the case notes of 80 patients who underwent parathyroid surgery (2003 to 2011). Patients were identified from the national BAETS audit.Results: Median age was 56 years (range 25–86). 72.5% of the patients were females and 30% were asymptomatic. Mean adjusted calcium con...

ea0028p51 | Clinical practice/governance and case reports | SFEBES2012

Audit of outcome of childhood onset growth hormone deficiency in young adults at the Royal Hospital for Sick Children, Yorkhill, Glasgow from 2005–2011.

Ahmid Mahjouba , Perry Colin , Donaldson Malcolm , Ahmed Syed , Shaikh M

Background: GH therapy in adolescents with childhood onset GH deficiency (CO-GHD) is often necessary to prevent adult GHD syndrome. This requires re-evaluation of the GH axis on attainment of final height.Aim: Retrospective review of outcome in young adults diagnosed with CO-GHD Design: Clinical details were collected on young adults with CO-GHD patients between 2005 and 2011 at one tertiary centre. Result: 62 former CO-GHD patients, 40 male: 22 female, ...

ea0027oc2.2 | Oral Communications 2 (Quick Fire) | BSPED2011

The assessment of bone microarchitecture by high resolution magnetic resonance imaging (micro MRI) in young adults with childhood onset disease

Yacoubian Calum , McComb Christie , Leddy Christopher , Ahmed Faisal , Foster John

Introduction: Dual energy X-ray absorptiometry (DXA) scans are regarded as the gold standard for assessing bone health. However, an inability to distinguish between cortical and trabecular bone as well as the use of inapproapriate size corrections mean that this technique is of limited clinical use in conditions affecting either bone microarchitecture or patient size. We have trialled the use of high resolution MRI (micro MRI) in the measurement of bone microarchitecture in pa...

ea0027p12 | (1) | BSPED2011

The European DSD register: a platform for International Collaborative Research

Rodie Martina , Sinnott Richard , Jiang Jipu , Ahmed Faisal

Effective research into understanding the aetiology of disorders of sex development (DSDs), as well as long-term outcome of these rare conditions, requires multicentre collaboration often across national boundaries. The EU-funded EuroDSD programme (www.eurodsd.eu) is one such collaboration involving clinical centres and clinical and genetic experts. At the heart of the EuroDSD collaboration is a DSD register that supports the sharing of DSD ...

ea0027p13 | (1) | BSPED2011

The dihydrotestosterone assay for identifying 5α-reductase deficiency: a five-year audit from a UK tertiary Paediatric Centre

Martin Iain , Smee Natalie , Mcneilly Jane , Rodie Martina , Ahmed Faisal

Background: The DHT RIA is often used in the assessment of children with suspected DSD. Affected cases have a history of consanguinity in ≤50% and many may not have a non-Caucasian background (Maimoun et al., JCEM, 2011). We aimed to assess the clinical utility of the DHT RIA in identifying cases of 5-ARD.Methods: All DHT requests in a 5 year period in a major UK tertiary paediatric centre were identified and case notes were retrieved and se...

ea0025p106 | Clinical biochemistry | SFEBES2011

Glucagon like peptide-1 in congestive heart failure cases and type 2 diabetes mellitus cases

Sheriba Nermin , Makboul Khaled , Abdelsalam Mona , Mohamed Hesham , Hamam Ahmed

GLP-1 stimulates β-cell proliferation, it also enhances the differentiation of new beta cells from progenitor cells in the pancreatic duct epithelium and it is capable of inhibiting apoptosis of β cells. GLP-1 also exhibits other effects of importance for glucose homeostasis, such as, inhibiting glucagon secretion, delaying gastric emptying, and stimulating insulin biosynthesis. These effects come along with a potential increase in peripheral insulin action. Type 2 d...

ea0025p153 | Diabetes, metabolism and cardiovascular | SFEBES2011

Glucagon like peptide-1 in congestive heart failure cases and type 2 diabetes mellitus cases

Sheriba Nrmin , Khaled Makboul , Abdelsalam Mona , Mohamed Hisham , Hamam Ahmed

GLP-1 stimulates β-cell proliferation, it also enhances the differentiation of new beta cells from progenitor cells in the pancreatic duct epithelium and it is capable of inhibiting apoptosis of beta cells. GLP-1 also exhibits other effects of importance for glucose homeostasis, such as, inhibiting glucagon secretion, delaying gastric emptying, and stimulating insulin biosynthesis. These effects come along with a potential increase in peripheral insulin action. Type 2 dia...